148 related articles for article (PubMed ID: 17090702)
1. A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2.
Ito Y; Takuma K; Mizoguchi H; Nagai T; Yamada K
J Pharmacol Exp Ther; 2007 Feb; 320(2):819-27. PubMed ID: 17090702
[TBL] [Abstract][Full Text] [Related]
2. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus.
Han F; Shioda N; Moriguchi S; Yamamoto Y; Raie AY; Yamaguchi Y; Hino M; Fukunaga K
J Pharmacol Exp Ther; 2008 Jul; 326(1):127-34. PubMed ID: 18388258
[TBL] [Abstract][Full Text] [Related]
3. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.
Kamei H; Nagai T; Nakano H; Togan Y; Takayanagi M; Takahashi K; Kobayashi K; Yoshida S; Maeda K; Takuma K; Nabeshima T; Yamada K
Biol Psychiatry; 2006 Jan; 59(1):75-84. PubMed ID: 16139811
[TBL] [Abstract][Full Text] [Related]
4. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
Noda Y; Mouri A; Ando Y; Waki Y; Yamada SN; Yoshimi A; Yamada K; Ozaki N; Wang D; Nabeshima T
Int J Neuropsychopharmacol; 2010 Nov; 13(10):1343-54. PubMed ID: 20219155
[TBL] [Abstract][Full Text] [Related]
5. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
7. A novel cognitive enhancer, ZSET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice.
Shioda N; Yamamoto Y; Han F; Moriguchi S; Yamaguchi Y; Hino M; Fukunaga K
J Pharmacol Exp Ther; 2010 Apr; 333(1):43-50. PubMed ID: 20068029
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex.
Nagai T; Takuma K; Kamei H; Ito Y; Nakamichi N; Ibi D; Nakanishi Y; Murai M; Mizoguchi H; Nabeshima T; Yamada K
Learn Mem; 2007 Mar; 14(3):117-25. PubMed ID: 17337702
[TBL] [Abstract][Full Text] [Related]
9. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism for methamphetamine-induced memory impairment].
Nagai T; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Apr; 45(2):81-91. PubMed ID: 20486560
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus.
Lee KW; Kim HC; Lee SY; Jang CG
Neuroscience; 2011 Mar; 178():101-7. PubMed ID: 21256196
[TBL] [Abstract][Full Text] [Related]
12. [Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior].
Shioda N; Yamamoto Y; Han F; Moriguchi S; Fukunaga K
Yakugaku Zasshi; 2011 Apr; 131(4):505-11. PubMed ID: 21467789
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute and chronic treatment with methamphetamine on mRNA expression of synaptotagmin IV and 25 KDa-synaptic-associated protein in the rat brain.
Isao T; Akiyama K
Psychiatry Clin Neurosci; 2004 Aug; 58(4):410-9. PubMed ID: 15298655
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
Suemaru J; Akiyama K; Tanabe Y; Kuroda S
Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
[TBL] [Abstract][Full Text] [Related]
15. Essential role of D1 but not D2 receptors in methamphetamine-induced impairment of long-term potentiation in hippocampal-prefrontal cortex pathway.
Ishikawa A; Kadota T; Kadota K; Matsumura H; Nakamura S
Eur J Neurosci; 2005 Oct; 22(7):1713-9. PubMed ID: 16197511
[TBL] [Abstract][Full Text] [Related]
16. Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling.
Nakajima A; Yamakuni T; Matsuzaki K; Nakata N; Onozuka H; Yokosuka A; Sashida Y; Mimaki Y; Ohizumi Y
J Pharmacol Exp Ther; 2007 May; 321(2):784-90. PubMed ID: 17289833
[TBL] [Abstract][Full Text] [Related]
17. Effect of methamphetamine on cognition and repetitive motor behavior of mice deficient for dopamine D2 and D3 receptors.
Glickstein SB; Schmauss C
Ann N Y Acad Sci; 2004 Oct; 1025():110-8. PubMed ID: 15542707
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of harmaline-induced tremor activity in mice.
Paterson NE; Malekiani SA; Foreman MM; Olivier B; Hanania T
Eur J Pharmacol; 2009 Aug; 616(1-3):73-80. PubMed ID: 19497322
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of Acetylcholine-Mediated Facilitation of Inhibitory Synaptic Transmission by an Azaindolizione Derivative, ZSET1446 (ST101), in the Rat Hippocampus.
Takeda K; Yamaguchi Y; Hino M; Kato F
J Pharmacol Exp Ther; 2016 Feb; 356(2):445-55. PubMed ID: 26578264
[TBL] [Abstract][Full Text] [Related]
20. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
Al Rahim M; Nakajima A; Saigusa D; Tetsu N; Maruyama Y; Shibuya M; Yamakoshi H; Tomioka Y; Iwabuchi Y; Ohizumi Y; Yamakuni T
Biochemistry; 2009 Aug; 48(32):7713-21. PubMed ID: 19601643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
